1) What is the difference between Semaglutide, Tirzepatide, and GLP3?

All three medications are designed to support weight loss and metabolic health, but they work through different hormone pathways.

• Semaglutide targets GLP-1, which helps regulate appetite, blood sugar, and digestion.
• Tirzepatide targets both GLP-1 and GIP, which may enhance weight loss and metabolic effects for some patients.
• GLP3, also known as Retatrutide, is a next-generation triple hormone peptide that targets GLP-1, GIP, and glucagon receptors, potentially supporting both appetite control and increased calorie burn.

The best option depends on your goals, body composition, medical history, and how your metabolism responds to treatment.

2) What is unique about Ravive’s non–big pharma approach?

At Ravive, our approach goes beyond simply prescribing medication.

Our programs are designed to provide:

• Personalized dosing protocols
• More flexibility than standard one-size-fits-all dosing
• Comprehensive nutritional guidance
• Body composition analysis
• Muscle-preservation focused weight loss
• Ongoing provider support and accountability

We focus on optimizing overall metabolic health, not just lowering the number on the scale. Our goal is sustainable fat loss while helping patients maintain lean muscle mass, energy, and long-term results.

3) What are the most common side effects?

The most common side effects with GLP-1 and peptide-based weight loss medications include:

• Nausea
• Reduced appetite
• Bloating
• Constipation
• Fatigue, especially during dose adjustments

Most side effects are temporary and improve as the body adapts. Our providers carefully structure dosing protocols to help minimize discomfort and improve tolerability.

4) If I feel nauseous, does that mean the medication is working better?

Not necessarily.

Mild appetite suppression is expected, but stronger side effects do not automatically mean better results. Excessive nausea may simply indicate that your dose is increasing too quickly or is higher than your body currently tolerates.

Our goal is sustainable fat loss with minimal side effects and optimal metabolic support.

5) How much weight can I lose?

Results vary from person to person, but clinical studies commonly show average weight loss ranges of:

• Semaglutide: approximately 10–15% body weight reduction
• Tirzepatide: approximately 15–22% body weight reduction
• GLP3: early clinical trials suggest the potential for even greater reductions in some patients by up to 30%

Results are heavily influenced by:

• Nutrition and lifestyle habits
• Consistency with treatment
• Sleep and stress management
• Metabolic health
• Coaching and accountability

At Ravive, we combine medication support with nutrition guidance and body composition monitoring to maximize long-term success.

6) How do these medications work?

These medications help regulate appetite, metabolism, and blood sugar through hormone signaling pathways.

They may:

• Slow stomach emptying to increase fullness
• Reduce hunger and cravings
• Improve blood sugar regulation
• Enhance insulin sensitivity
• Support healthier metabolic function
• Help patients feel satisfied with smaller portions

When paired with proper nutrition and lifestyle support, these treatments can be highly effective tools for sustainable weight loss.

7) Who is a good candidate for these treatments?

You may be a good candidate if you:

• Struggle to lose weight despite diet and exercise
• Experience persistent cravings or appetite dysregulation
• Have metabolic resistance or insulin resistance
• Want medical support for sustainable fat loss
• Are looking to improve overall metabolic health

A consultation with our team helps determine the safest and most effective treatment approach for your individual goals.

8) What is the difference between GLP3 vs Tirzepatide and Semaglutide?

The primary difference is the number of metabolic pathways each medication targets.

• Semaglutide works on GLP-1 only
• Tirzepatide works on GLP-1 + GIP
• GLP3 works on GLP-1 + GIP + glucagon receptors

Because GLP3 activates three metabolic pathways instead of one or two, early research suggests it may support:

• Greater appetite control
• Increased energy expenditure
• Enhanced metabolic activity
• More significant body composition changes for some patients

As peptide science continues to evolve, GLP3 represents one of the newest developments in metabolic and weight management therapy.

9) Should I expect sustainable results from the medication alone?

While these medications can significantly improve appetite control and metabolic function, long-term results are best achieved when combined with healthy lifestyle habits.

At Ravive, we provide:

• Personalized nutrition guidance
• Body composition analysis
• Muscle-preservation strategies
• Lifestyle coaching

We focus on helping patients lose fat while maintaining lean muscle mass for healthier, more sustainable outcomes.

10) Do you offer consultations?

Yes — we offer complimentary consultations to discuss your goals, review your health history, and create a personalized treatment plan tailored to your needs.